BackCF Acquisition VII Overview

CF Acquisition VII Total Liabilities

CF Acquisition VII's total liabilities is $13M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$12.74M
↑ 43.10% YoYΔ $3.84M vs prior year quarter

Peer average

Loading

CF Acquisition VII Total Liabilities History

Loading

CF Acquisition VII vs. peers: Total Liabilities Comparison

Loading

CF Acquisition VII Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CF Acquisition VII (CFFS) FAQ

CF Acquisition VII (CFFS) currently reports a total liabilities of $13M as of September 2024. That compares with $8.9M in the prior-year period — up 43.1% year over year. Use the charts on this page to explore CF Acquisition VII's total liabilities history and peer comparisons.

CF Acquisition VII's total liabilities increased from $8.9M to $13M — a 43.1% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CF Acquisition VII reported $13M in total liabilities as of September 2024. That compares with $8.9M in the prior-year period — up 43.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CF Acquisition VII, and consider following CFFS for alerts when major investors trade the stock.